Kognitivní strategie pro optimalizaci zdraví mozku a řízení transgeneračních vaskulárních rizikových faktorů po mrtvici (CHAMPS-TR)
Kognitivní strategie pro optimalizaci zdraví mozku a řízení transgeneračních vaskulárních rizikových faktorů po mrtvici (CHAMPS pro transgenerační riziko)
People living with the cognitive effects of stroke are at risk for recurrent stroke and further cognitive decline. Also problematic is that stroke risk clusters in families and biological family members of people who have ischemic stroke may also be at increased risk of stroke and/or cognitive decline. The primary goal of this study is to test the feasibility of a virtually delivered cognitive strategy training and health coaching program to reduce vascular risk and promote brain health in persons with stroke and their biological family members.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Detailní popis
CHAMPS for Transgenerational Risk (TR) (Cognitive strategies for optimizing brain Health And Managing transgenerational vascular risk factors Post-Stroke), a feasibility trial for preventing stroke and improving cognitive outcomes in persons with stroke and their families. Stroke is used as a vector to identify both persons with post-stroke cognitive impairment and dementia (PSCID)and a targeted family member who may be at risk and could benefit from vascular risk reduction intervention. The investigators integrate the concept of a "teachable moment" where health events can lead to behavior change by targeting family members who are stroke-free but may have vascular risk factors putting them at risk for stroke and vascular cognitive impairment (VCI) in the future. Recognizing that people with stroke frequently encounter barriers to community mobility, the proposed trial will be offered virtually to give even those with difficulty accessing the community an equitable opportunity to participate in clinical research.
In this feasibility trial, the investigators will pilot test the CHAMPS-TR intervention which includes vascular risk reduction coaching and a metacognitive problem-solving protocol which contains guided discovery, goal setting, and strategy training. Index persons with stroke and targeted family members (i.e., biological child, younger sibling) who may be at heightened risk for stroke and VCI will receive the CHAMPS intervention which will be delivered remotely. Participants will be split into two arms and either receive the virtual CHAMPS-TR intervention or CHAMPS-TR intervention plus remotely-supervised transcranial Direct Current Stimulation (RS-tDCS) based on eligibility and preference. tDCS is a minimally invasive brain stimulation technique that may augment the effects of cognitive interventions alone. It has strong evidence in stroke rehabilitation and RS-tDCS is a feasible approach in those with stroke and other clinical populations. The overarching goal of this project is to rigorously test the custom-tailored intervention for families impacted by ischemic stroke.
Typ studie
Typ studie
Zápis (Odhadovaný)
Zápis
Fáze
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
New Mexico
-
Albuquerque, New Mexico, Spojené státy, 87131
- University of New Mexico Health Sciences Center
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- primary diagnosis of acute ischemic stroke,
- impairment of cognitive function (score >1 on Quick Executive Interview - telephone screener),
- absence of severe aphasia (score of 0 or 1 on NIH Stroke Scale),
- absence of pre-stroke dementia (client report),
- absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
- absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
- greater than 40 years of age,
- having a potential family member who meets targeted family member criteria,
- eligible for MRI and Remote Supervised-transcranial direct current stimulation (RS-tDCS) if in CHAMPS-TR plus RS-tDCS (e.g., not pregnant; no intracranial metal implants; no skin lesions on target sites for stimulation; no severe cardiopulmonary, renal or hepatic diseases; no pacemakers; no underlying medical reason for not engaging in MRI or tDCS).
The targeted family member will be:
- a minimum of 18 years of age,
- biological kin of person with stroke,
- absence of dementia (client report),
- absence of major anxiety and depressive disorder (PHQ-9, GAD-7),
- absence of drug and alcohol misuse within 3 months of study (AUDIT, DAST),
- greater than 18 years of age, and
- having a sibling or parent who had an ischemic stroke
Exclusion Criteria:
For all participants:
- not English speaking, reading, and understanding, and
- no access to video-conference software on a computer or smart device
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Nerandomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Experimentální: CHAMPS-TR
Persons with stroke and a targeted biological family member will receive the CHAMPS intervention including vascular risk reduction coaching and cognitive strategy training. |
Persons with stroke ( n=20) and at least 1 targeted family member (TFM) (n=20) will engage with the CHAMPS-TR protocol which involves 10 virtual intervention sessions (bi-weekly for 5 weeks) with key elements including metacognitive problem-solving training (i.e., goal setting, guided discovery, strategy development) and vascular risk reduction coaching building on existing American Heart Association (AHA) LE8 content. Probands that are eligible for RS-tDCS (n=10) will receive 5x weekly (weeks 2-5) RS-tDCS applied to the left dorsolateral prefrontal cortex (DLPFC). |
|
Experimentální: CHAMPS TR plus remotely supervised transcranial direct current stimulation (RS-tDCS)
Persons with stroke and a targeted biological family member will receive the CHAMPS intervention including vascular risk reduction coaching and cognitive strategy training. Persons with stroke will also receive RS-tDCS. |
Persons with stroke ( n=20) and at least 1 targeted family member (TFM) (n=20) will engage with the CHAMPS-TR protocol which involves 10 virtual intervention sessions (bi-weekly for 5 weeks) with key elements including metacognitive problem-solving training (i.e., goal setting, guided discovery, strategy development) and vascular risk reduction coaching building on existing American Heart Association (AHA) LE8 content. Probands that are eligible for RS-tDCS (n=10) will receive 5x weekly (weeks 2-5) RS-tDCS applied to the left dorsolateral prefrontal cortex (DLPFC). |
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
American Heart Association Life's Essential 8 Metrics
Časové okno: baseline, up to 7 weeks, and up to 24 weeks
|
metric scores for vascular risk; score is calculated on a 0-100 scale where 100 is ideal |
baseline, up to 7 weeks, and up to 24 weeks
|
|
Cardiovascular risk factors, Aging, and Incidence of Dementia (CAIDE)
Časové okno: baseline, up to 7 weeks, and up to 24 weeks
|
Risk profile score for cognitive decline; score is composed of weightings by reference to age, sex, education, systolic blood pressure, BMI, total cholesterol, and physical activity. Scores range from 0-15 with higher scores indicating greater risk. |
baseline, up to 7 weeks, and up to 24 weeks
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Oral Trail Making Test Part B
Časové okno: baseline and up to 24 weeks
|
Test of mental sequencing and switching; score with total number of seconds to complete up to 300, total number of errors, and total correct |
baseline and up to 24 weeks
|
|
Number Span Test Forward and Backward
Časové okno: baseline and up to 24 weeks
|
Test of working memory; scored with number of correct trials (0-14), and longest span forward (0, 3-9) and longest span backward (0, 2-8). Higher numbers are greater number of correct items. |
baseline and up to 24 weeks
|
|
Multiple Errands Test Home Version
Časové okno: baseline and up to 24 weeks
|
Test of executive function impact on everyday life; total score of 0-14 with higher levels indicating less impairment; additional sub-scores for errors made and strategies used using total scores. |
baseline and up to 24 weeks
|
|
Mark VCID2 Clinical Cognitive Assessment Battery
Časové okno: baseline and up to 24 weeks
|
Test of cognitive impairment and dementia; total scores on all sub-scores for each included measure. |
baseline and up to 24 weeks
|
|
PROMIS Self-Efficacy for Managing Medications
Časové okno: baseline, up to 7 weeks, and up to 24 weeks
|
Test of self efficacy for managing medications; scoring with item-level calibrations using HealthMeasures Scoring Service |
baseline, up to 7 weeks, and up to 24 weeks
|
|
PROMIS Self-Efficacy for Managing Symptoms
Časové okno: baseline, up to 7 weeks, and up to 24 weeks
|
Test of self efficacy for managing symptoms; scoring with item-level calibrations using HealthMeasures Scoring Service |
baseline, up to 7 weeks, and up to 24 weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Začátek studia
Primární dokončení (Aktuální)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- HRRCID 23-332
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Data Sharing Plan
The investigators will share data collected in this project:
At National Scientific Meetings: The investigators expect to share results from the data at two conferences/scientific meetings a year such as the American Congress of Medical Rehabilitation Conference, the RESNA conference, the American Occupational Therapy Conference, and Aging Conferences.
Through Publication in Scientific Journals: the investigators expect to publish 1-2 journal articles a year where data from the proposed project will be shared with no subject identifiers.
Data to be shared includes de-identified: MRI data, feasibility data, self-efficacy scores, vascular risk factor scores, cognitive/executive function scores
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .